Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
View Older Stories View More Recent Stories
-
Early Bird Registration Now Open for the Inaugural OpenSSL Conference 2025
-
TelevisaUnivision Appoints John Farrell as Head of Partnerships
-
Bernstein Reiterates Outperform Rating on Air Products & Chemicals Inc. (APD)
-
Anheuser-Busch InBev (BUD) PT Lowered at Bernstein; 'The Panic Is Massively Overdone'
-
Grab Holdings Inc. (GRAB) PT Raised to $5.60 at Bernstein on Growth Potential
-
Ferrari (RACE) PT Lowered to $554 at Bernstein
-
AGCO Corporation (AGCO) PT Raised to $118 at Bernstein
-
Bernstein on Quanta Services (PWR): 'Growth Continues'
-
Cognex (CGNX) PT Raised at Bernstein; 'A Solid Recovery Starts'
-
US plans to test Medicare, Medicaid coverage for weight-loss drugs, Washington Post reports
-
Big Beer plans sales push from Brazil to China with volumes in focus
-
Here's why you should avoid owning this popular car stock: Bernstein
-
Tandem Diabetes Care Announces Upcoming Conference Participation
-
Television Academy’s Premiere Televerse Festival Announces New Star-Driven and One-of-a-Kind Behind-the-Scenes Experiences for High-Powered August Debut
-
Asia Go IPO Summit 2025 Unveils Speaker Lineup and Agenda
-
Mastercard Q2 earnings preview: analysts watch growth signs amid stablecoin concerns
-
Lufthansa, Air France-KLM defy trade war worries with Q2 growth
-
Accor earnings: Bernstein forecasts solid results
-
Form 497 BERNSTEIN SANFORD C FUND
-
Bernstein: World needs a TSMC alternative-and this name is best positioned
-
Here's why Microsoft's AI plans will be in focus in the tech giant's Q4 earnings
-
Bernstein Recommends Starbucks (SBUX) to Patient Investors
-
Bernstein on Palo Alto Networks (PANW): 'CyberArk... To Buy or Not To Buy?'
-
Spotify (SPOT) Drops 11%, Bernstein Sees Attractive Entry Point
-
Bernstein Reiterates Outperform Rating on Royal Caribbean Cruises (RCL)
-
Bernstein Reiterates Market Perform Rating on Titan America (TTAM)
-
Boeing (BA) PT Raised to $287 at Bernstein as 'Upward Trajectory Continues'
-
Sarepta Therapeutics (SRPT) PT Raised to $18 at Bernstein
-
Alnylam Pharmaceuticals (ALNY) PT Raised to $389 at Bernstein SocGen Group
-
Hubbell (HUBB) PT Raised to $511 at Bernstein SocGen Group
-
Mondelez International (MDLZ) PT Raised to $88 at Bernstein SocGen Group
-
Qualcomm set to report Q3 earnings amid Apple headwinds, cautious outlook ahead
-
Kering shares rise as market looks past a weak second quarter
-
Japan Post Insurance Invests $2 Billion in Global Atlantic Vehicle
-
Aston Martin warns on profit as US tariffs, stagnant Chinese demand bite
-
Hermes reports 9% sales rise but flags some weakness, shares down
-
H1 2025: Outstanding delivery of Nexans’ model, 2025 guidance upgraded
-
Acadia Realty Trust Reports Second Quarter Operating Results
-
Bernstein Reiterates Outperform Rating on Microsoft (MSFT)
-
Bernstein Reiterates Market Perform Rating on Comcast Corp (CMCSA)
-
Revvity Inc (RVTY) PT Lowered to $115 at Bernstein on Lower Estimates
-
Bernstein Reiterates Outperform Rating on UnitedHealth Group (UNH)
-
TechnipFMC (FTI) PT Raised at Bernstein Following 'A Strong Set of 2Q25 Results'
-
Merck extends pause on China Gardasil shipments to year end, shares slip
-
Bernstein SocGen Group Starts Sarepta Therapeutics (SRPT) at Market Perform
-
Analysts eye Spotify's Q2 earnings amid subscriber gains and price hikes
-
Boeing Q2 earnings preview: analysts focus on production ramp-up
-
Air Liquide: Analysts expect muted Q2 growth
-
Form 4 Airbnb, Inc. For: Jul 24 Filed by: Bernstein David C
-
EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say
